Semaglutide

Semaglutide is a long-acting GLP-1 receptor agonist studied for its effects on metabolic signaling, glucose regulation, appetite pathways, gastric emptying, and body-weight regulation. In research models and clinical study settings, GLP-1 receptor activation is associated with enhanced glucose-dependent insulin secretion, reduced glucagon output, slower gastric emptying, and increased satiety signaling through central and peripheral pathways. Semaglutide has become one of the most widely studied incretin-based compounds because of its relevance to obesity, insulin resistance, cardiometabolic risk, and appetite regulation. It remains a cornerstone compound for studying how gut hormone signaling influences metabolism.